期刊
NATURE
卷 453, 期 7191, 页码 65-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nature06880
关键词
-
资金
- NIAID NIH HHS [R01 AI073542, R01AI073542-01, R01 AI073542-02, R01 AI073542-01, AI435801] Funding Source: Medline
- NINDS NIH HHS [P01 NS038037, NS38037, R01 NS059996] Funding Source: Medline
Regulatory T cells (T-reg) expressing the transcription factor Foxp3 control the autoreactive components of the immune system. The development of T-reg cells is reciprocally related to that of pro- inflammatory T cells producing interleukin- 17 ( T(H)17). Although T-reg cell dysfunction and/ or T(H)17 cell dysregulation are thought to contribute to the development of autoimmune disorders, little is known about the physiological pathways that control the generation of these cell lineages. Here we report the identification of the ligand- activated transcription factor aryl hydrocarbon receptor ( AHR) as a regulator of T-reg and T(H)17 cell differentiation in mice. AHR activation by its ligand 2,3,7,8- tetrachlorodibenzo- p- dioxin induced functional Treg cells that suppressed experimental autoimmune encephalomyelitis. On the other hand, AHR activation by 6- formylindolo[ 3,2- b] carbazole interfered with T-reg cell development, boosted T(H)17 cell differentiation and increased the severity of experimental autoimmune encephalomyelitis in mice. Thus, AHR regulates both T-reg and T(H)17 cell differentiation in a ligand- specific fashion, constituting a unique target for therapeutic immunomodulation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据